A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...

The purpose of this research is to define the conditions under which developing countries find themselves implementing Artificial Intelligence in their governance systems. This scientific contribution ...

Introduction Adolescents in Kenya face a high burden of sexual and reproductive health (SRH) challenges, including early pregnancy, sexually transmitted infections and limited access to accurate ...

Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...

A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that ...

Each year we gain new talent in Seattle and we lose inimitable resources. As a tribute, and on behalf of the entire ...

This Research Topic is Volume II of a series. The previous volume, which has attracted over 21k views can be found here:Transforming Chronic Disease ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

The dual-track analysis confirms that the Jordanian Paradox is influenced by deeply rooted, intersecting institutional ...

Composite endpoints are widely used in large randomised cardiovascular outcome trials. They are frequently referred to as ...

Background The landscape of tobacco and nicotine delivery products has rapidly evolved with the introduction of electronic nicotine delivery systems (ENDSs) and oral nicotine pouches (ONPs).

Artificial intelligence (AI) is revolutionising the field of drug discovery and disease modelling, with a significant impact ...